Next Article in Journal
Anal Cancer and Human Papillomaviruses in Heterosexual Men
Previous Article in Journal
Cetuximab Treatment in a Patient with Metastatic Colorectal Cancer and Psoriasis
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Side Effects Related to Systemic Cancer Treatment: Are We Changing the Promethean Experience with Molecularly Targeted Therapies?

by
Carlo De Angelis
Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON M4N 3M5, Canada
Curr. Oncol. 2008, 15(4), 198-199; https://doi.org/10.3747/co.v15i4.362
Submission received: 5 May 2008 / Revised: 6 June 2008 / Accepted: 7 July 2008 / Published: 1 August 2008

Abstract

For having stolen fire and given it to mankind, Prometheus was punished by Zeus by being chained to the side of Mount Caucasus, where, every day, an eagle would eat away at his liver. [...]

Share and Cite

MDPI and ACS Style

De Angelis, C. Side Effects Related to Systemic Cancer Treatment: Are We Changing the Promethean Experience with Molecularly Targeted Therapies? Curr. Oncol. 2008, 15, 198-199. https://doi.org/10.3747/co.v15i4.362

AMA Style

De Angelis C. Side Effects Related to Systemic Cancer Treatment: Are We Changing the Promethean Experience with Molecularly Targeted Therapies? Current Oncology. 2008; 15(4):198-199. https://doi.org/10.3747/co.v15i4.362

Chicago/Turabian Style

De Angelis, Carlo. 2008. "Side Effects Related to Systemic Cancer Treatment: Are We Changing the Promethean Experience with Molecularly Targeted Therapies?" Current Oncology 15, no. 4: 198-199. https://doi.org/10.3747/co.v15i4.362

APA Style

De Angelis, C. (2008). Side Effects Related to Systemic Cancer Treatment: Are We Changing the Promethean Experience with Molecularly Targeted Therapies? Current Oncology, 15(4), 198-199. https://doi.org/10.3747/co.v15i4.362

Article Metrics

Back to TopTop